The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
Open accessAbstract
Nijiro Nohata 1,2 , Toyoyuki Hanazawa 2 , Hideki Enokida 3 , Naohiko Seki 1 1 Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan 2 Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan 3 Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan Received: January 25, 2012; Accepted: January 25, 2012; Published: February 4, 2012; Keywords: cancer, miRNA, miR-1, miR-133a, miR-133b, miR-206 Correspondence: Naohiko Seki, email: // // Abstract MicroRNAs (miRNAs) are endogenous short non-coding RNA molecules that regulate gene expression by repressing translation or cleaving RNA transcripts in a sequence-specific manner. A growing body of evidence suggests that miRNAs are aberrantly expressed in many human cancers and that they play significant roles in the initiation, development and metastasis of human cancers. Genome-wide miRNA expression signatures provide information on the aberrant expression of miRNAs in cancers rapidly and precisely. Recently, studies from our group and others revealed that microRNA-1 (miR-1), microRNA-133a (miR-133a), microRNA-133b (miR-133b) and microRNA-206 (miR-206) are frequently downregulated in various types of cancers. Interestingly, miR-1-1/miR-133a-2, miR-1-2/miR-133a-1, and miR-206/miR-133b form clusters in three different chromosomal regions of the human genome – 20q13.33, 18q11.2 and 6p12.1, respectively. Here we review highlights of recent findings on the aberrant expression and functional significance of the miR-1/miR-133a and miR-206/miR-133b clusters in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Datta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
RetractedNasser, M. W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S. T., & Ghoshal, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804788200 · Cited by 360
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J.-F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2006) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,779
Identification of Mammalian microRNA Host Genes and Transcription Units
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., & Bradley, A. (2004) · Genome Research · doi:10.1101/gr.2722704 · Cited by 2,128
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,770
BASKERVILLE, S., & BARTEL, D. P. (2005) · RNA · doi:10.1261/rna.7240905 · Cited by 1,508
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 810
Clustering and conservation patterns of human microRNAs
Altuvia, Y. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki567 · Cited by 802
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
Wong, T.-S., Liu, X.-B., Wong, B. Y.-H., Ng, R. W.-M., Yuen, A. P.-W., & Wei, W. I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0666 · Cited by 750
Ambs, S., Prueitt, R. L., Yi, M., Hudson, R. S., Howe, T. M., Petrocca, F., Wallace, T. A., Liu, C.-G., Volinia, S., Calin, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0144 · Cited by 704
Szafranska, A. E., Davison, T. S., John, J., Cannon, T., Sipos, B., Maghnouj, A., Labourier, E., & Hahn, S. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210228 · Cited by 664
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
Aqeilan, R. I., Calin, G. A., & Croce, C. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.69 · Cited by 648
GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists
Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M., & Pascual-Montano, A. (2007) · Genome Biology · doi:10.1186/gb-2007-8-1-r3 · Cited by 592
mir-17-92, a cluster of miRNAs in the midst of the cancer network
Olive, V., Jiang, I., & He, L. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.004 · Cited by 465
Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y., Chiyomaru, T., Enokida, H., Nakagawa, M., & Matsubara, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25284 · Cited by 441
Self-citationNogales-Cadenas, R., Carmona-Saez, P., Vazquez, M., Vicente, C., Yang, X., Tirado, F., Carazo, J. M., & Pascual-Montano, A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp416 · Cited by 437
Serum microRNAs as non-invasive biomarkers for cancer
Brase, J. C., Wuttig, D., Kuner, R., & Sültmann, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-306 · Cited by 421
Liu, R., Zhang, C., Hu, Z., Li, G., Wang, C., Yang, C., Huang, D., Chen, X., Zhang, H., Zhuang, R., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.025 · Cited by 408
Childs, G., Fazzari, M., Kung, G., Kawachi, N., Brandwein-Gensler, M., McLemore, M., Chen, Q., Burk, R. D., Smith, R. V., Prystowsky, M. B., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080731 · Cited by 364
Dyrskjøt, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4043 · Cited by 363
Townley-Tilson, W. H. D., Callis, T. E., & Wang, D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.002 · Cited by 355
Survival prediction of gastric cancer by a seven-microRNA signature
Li, X., Zhang, Y., Zhang, Y., Ding, J., Wu, K., & Fan, D. (2010) · Gut · doi:10.1136/gut.2008.175497 · Cited by 330
Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 325
Self-citationChhabra, R., Dubey, R., & Saini, N. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-232 · Cited by 324
Sarver, A. L., French, A. J., Borralho, P. M., Thayanithy, V., Oberg, A. L., Silverstein, K. A., Morlan, B. W., Riska, S. M., Boardman, L. A., Cunningham, J. M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-401 · Cited by 310
miR-206 Expression Is Down-regulated in Estrogen Receptor α–Positive Human Breast Cancer
Kondo, N., Toyama, T., Sugiura, H., Fujii, Y., & Yamashita, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0180 · Cited by 298
Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines
Yu, J., Wang, F., Yang, G.-H., Wang, F.-L., Ma, Y.-N., Du, Z.-W., & Zhang, J.-W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.207 · Cited by 291
MicroRNAs and cancer: past, present, and potential future
Nelson, K. M., & Weiss, G. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0586 · Cited by 279
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
Yoshino, H., Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Nishiyama, K., Nohata, N., Seki, N., & Nakagawa, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.23 · Cited by 273
Self-citationMicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development
Yan, D., Dong, X. D., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J., & Tu, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020511 · Cited by 271
Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., Tuschl, T., & Ponzetto, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38075 · Cited by 260
MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
Radojicic, J., Zaravinos, A., Vrekoussis, T., Kafousi, M., Spandidos, D. A., & Stathopoulos, E. N. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14754 · Cited by 256
Leivonen, S.-K., Mäkelä, R., Östling, P., Kohonen, P., Haapa-Paananen, S., Kleivi, K., Enerly, E., Aakula, A., Hellström, K., Sahlberg, N., et al. (2009) · Oncogene · doi:10.1038/onc.2009.241 · Cited by 243
MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
Yip, L., Kelly, L., Shuai, Y., Armstrong, M. J., Nikiforov, Y. E., Carty, S. E., & Nikiforova, M. N. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1733-0 · Cited by 242
Smits, M., Nilsson, J., Mir, S. E., van der Stoop, P. M., Hulleman, E., Niers, J. M., de Witt Hamer, P. C., Marquez, V. E., Cloos, J., Krichevsky, A. M., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.205 · Cited by 236
Rossi, S., Shimizu, M., Barbarotto, E., Nicoloso, M. S., Dimitri, F., Sampath, D., Fabbri, M., Lerner, S., Barron, L. L., Rassenti, L. Z., et al. (2010) · Blood · doi:10.1182/blood-2010-01-263889 · Cited by 212
Song, G., Zhang, Y., & Wang, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046862 · Cited by 211
Gutiérrez, N. C., Sarasquete, M. E., Misiewicz-Krzeminska, I., Delgado, M., De Las Rivas, J., Ticona, F. V., Fermiñán, E., Martín-Jiménez, P., Chillón, C., Risueño, A., et al. (2010) · Leukemia · doi:10.1038/leu.2009.274 · Cited by 211
Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011) · Aging · doi:10.18632/aging.100285 · Cited by 207
Kojima, S., Chiyomaru, T., Kawakami, K., Yoshino, H., Enokida, H., Nohata, N., Fuse, M., Ichikawa, T., Naya, Y., Nakagawa, M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.462 · Cited by 199
Self-citationMicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways
Davis-Dusenbery, B. N., & Hata, A. (2010) · Genes & Cancer · doi:10.1177/1947601910396213 · Cited by 192
Wong, T., Liu, X., Chung‐Wai Ho, A., Po‐Wing Yuen, A., Wai‐Man Ng, R., & Ignace Wei, W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23583 · Cited by 188
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer
Crawford, M., Batte, K., Yu, L., Wu, X., Nuovo, G. J., Marsh, C. B., Otterson, G. A., & Nana-Sinkam, S. P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.143 · Cited by 176
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
Nohata, N., Sone, Y., Hanazawa, T., Fuse, M., Kikkawa, N., Yoshino, H., Chiyomaru, T., Kawakami, K., Enokida, H., Nakagawa, M., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.213 · Cited by 176
Self-citationSuzuki, H., Takatsuka, S., Akashi, H., Yamamoto, E., Nojima, M., Maruyama, R., Kai, M., Yamano, H.-O., Sasaki, Y., Tokino, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1076 · Cited by 158
Akçakaya, P. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1043 · Cited by 151
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells
Noonan, E. J., Place, R. F., Basak, S., Pookot, D., & Li, L. (2010) · Oncotarget · doi:10.18632/oncotarget.167 · Cited by 149
Tăcutu, R., Budovsky, A., Yanai, H., & Fraifeld, V. E. (2011) · Aging · doi:10.18632/aging.100413 · Cited by 147
Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma
Miyachi, M., Tsuchiya, K., Yoshida, H., Yagyu, S., Kikuchi, K., Misawa, A., Iehara, T., & Hosoi, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.015 · Cited by 133
Ma, Y., Zhang, P., Yang, J., Liu, Z., Yang, Z., & Qin, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26232 · Cited by 133
Rao, P. K., Missiaglia, E., Shields, L. Y., Hyde, G., Yuan, B., Shepherd, C. J., SHIPLEY, J. M., & Lodish, H. F. (2010) · The FASEB Journal · doi:10.1096/fj.09-150698 · Cited by 132
Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma
Moriya, Y., Nohata, N., Kinoshita, T., Mutallip, M., Okamoto, T., Yoshida, S., Suzuki, M., Yoshino, I., & Seki, N. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.126 · Cited by 123
Self-citationMicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
Missiaglia, E., Shepherd, C. J., Patel, S. A., Thway, K., Pierron, G., Pritchard‐Jones, K., Renard, M., Sciot, R., Rao, P. K., Oberlin, O., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605684 · Cited by 121
Seki (2010) · International Journal of Oncology · doi:10.3892/ijo_00000840 · Cited by 121
Hu, G. M., Chen, D., Li, X., Yang, K., Wang, H., & Wu, W. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.2.12186 · Cited by 120
Callis, T. E., & Wang, D. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.03.006 · Cited by 117
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer
Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Uchida, Y., Kawahara, K., Nishiyama, K., Seki, N., & Nakagawa, M. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.05.008 · Cited by 117
Self-citationMiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1α
Leone, V., D’Angelo, D., Rubio, I. G. S., de Freitas, P. M., Federico, A., Colamaio, M., Pallante, P., Medeiros-Neto, G. A., & Fusco, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0345 · Cited by 116
MicroRNA‐206 Is Associated With Invasion and Metastasis of Lung Cancer
Wang, X., Ling, C., Bai, Y., & Zhao, J. (2010) · The Anatomical Record · doi:10.1002/ar.21287 · Cited by 104
MicroRNA signatures differentiate melanoma subtypes
Chan, E., Patel, R., Nallur, S. V., Ratner, E., Bacchiocchi, A., Hoyt, K., Szpakowski, S., Godshalk, S. E., Ariyan, S., Sznol, M., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15777 · Cited by 100
Chen, X., Qin, Y., Li, S., Zhou, L., Yang, H., Yang, Y., Liu, X., & Wan, X. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.014 · Cited by 98
Differential miRNA expression profiles in bladder urothelial carcinomas.
Song, T., Xia, W., Shao, N., Zhang, X., Wang, C., Wu, Y., Dong, J., Cai, W., & Li, H. (2010) · PubMed · Cited by 90
Yoshino, H., Enokida, H., Chiyomaru, T., Tatarano, S., Hidaka, H., Yamasaki, T., Gotanda, T., Tachiwada, T., Nohata, N., Yamane, T., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.011 · Cited by 89
Self-citationCancer microRNAs: From subtype profiling to predictors of response to therapy
Chan, E., Prado, D. E., & Weidhaas, J. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.008 · Cited by 77
Wang, F., Song, G., Liu, M., Li, X., & Tang, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.052 · Cited by 70
A precursor microRNA in a cancer cell nucleus: Get me out of here!
Melo, S. A., & Esteller, M. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15119 · Cited by 48
Ory, B., & Ellisen, L. W. (2011) · Oncotarget · doi:10.18632/oncotarget.244 · Cited by 47
Potentially predictive microRNAs of gastric cancer with metastasis to lymph node
Wu, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i31.3645 · Cited by 43
Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs
Mavrakis, K. J., Leslie, C. S., & Wendel, H. (2011) · Cell Cycle · doi:10.4161/cc.10.17.16959 · Cited by 34
A TSH-CREB1-microRNA Loop Is Required for Thyroid Cell Growth
Leone, V., D’Angelo, D., Ferraro, A., Pallante, P., Rubio, I. G. S., Santoro, M. M., Croce, C. M., & Fusco, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0014 · Cited by 33
miRNA signature of schwannomas: Possible role(s) of “tumor suppressor” miRNAs in benign tumors
Erkan, E. P., Breakefield, X. O., & Saydam, O. (2011) · Oncotarget · doi:10.18632/oncotarget.251 · Cited by 25
Cited by
Muscle-specific microRNAs in skeletal muscle development
Horak, M., Novak, J., & Bienertova-Vasku, J. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2015.12.013 · Cited by 478
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
Cheng, J., Meng, J., Zhu, L., & Peng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01189-3 · Cited by 319
Bronisz, A., Wang, Y., Nowicki, M. O., Peruzzi, P., Ansari, K. I., Ogawa, D., Balaj, L., De Rienzo, G., Mineo, M., Nakano, I., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2650 · Cited by 222
Kumar, B., Rosenberg, A. Z., Choi, S. M., Fox-Talbot, K., De Marzo, A. M., Nonn, L., Brennen, W. N., Marchionni, L., Halushka, M. K., & Lupold, S. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25320-z · Cited by 48
Metadata
- Authors
- Nohata, N., Hanazawa, T., Enokida, H., & Seki, N.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2012-01-31
- Volume
- 3
- Issue
- 1
- Pages
- 9-21
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1744006947
- Cited by
- 253
- References
- 85
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.